Showing 64,901 - 64,920 results of 108,452 for search '(( a point decrease ) OR ( 5 ((((step decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.66s Refine Results
  1. 64901

    Rapid and long-lasting antidepressant-like effects of ketamine and their relationship with the expression of brain enzymes, BDNF, and astrocytes by G.S.B. Viana (6303023)

    Published 2021
    “…A single dose of KET (2, 5, or 10 mg/kg, po) was administered to male Swiss mice and the forced swim test (FST) was performed 30 min, 15, or 30 days later. …”
  2. 64902

    GFP fluorescence imaging of PIT <i>in vivo</i> in bilateral N87-GFP flank model. by Kazuhide Sato (662171)

    Published 2014
    “…<p>(A) PIT regimen. Fluorescence images were obtained at each time point as indicated. …”
  3. 64903

    Image1_Comparison of perventricular and percutaneous ultrasound-guided device closure of perimembranous ventricular septal defects.tif by Liu Liu Huang (17339485)

    Published 2023
    “…</p>Results<p>Patients of the PCP and PVP groups had a median age of 4.9 years (IQR, 3.1–14.0) and 5.3 years (IQR, 3.4–13.1) respectively. …”
  4. 64904

    Multi-way sensitivity analysis on regional access to care and linkage to care with POC-CD4 compared to LAB-CD4. by Emily P. Hyle (512613)

    Published 2014
    “…<p>Projected decrease in 5-y mortality and ICERs with use of POC-CD4 compared to LAB-CD4 in four settings that represent a range of access to care (decreasing access to care from left to right) and with different probabilities of linkage with POC-CD4 (increasing up the vertical axis). …”
  5. 64905

    Feeding rate and feeding frequency affect growth performance of common snook (Centropomus undecimalis) juveniles reared in the laboratory by Ricardo Luís Mendes de Oliveira (6484895)

    Published 2019
    “…The experimental design was a 3 × 3 factorial with three feeding frequencies (F2, F4, and F6: two, four, and six daily meals, respectively), three feeding rates (R1, R2.5, and R4: 1.0, 2.5, and 4.0%/day of fish biomass, respectively), and three replicates, totaling nine treatments (F2R1, F2R2.5, F2R4; F4R1, F4R2.5, F4R4; F6R1, F6R2.5, and F6R4). …”
  6. 64906

    Effects of HDAC8 inhibition on MPNST cell cycle and apoptosis. by Gonzalo Lopez (22820)

    Published 2015
    “…<p><b>A.</b> PI staining/FACS analyses showing the effect of HDACis (PCI2 0.5μM/48h, PCI3/4 5μM/48h) on human and murine-derived MPNST cell cycle progression. …”
  7. 64907

    Table2_Comparison of perventricular and percutaneous ultrasound-guided device closure of perimembranous ventricular septal defects.docx by Liu Liu Huang (17339485)

    Published 2023
    “…</p>Results<p>Patients of the PCP and PVP groups had a median age of 4.9 years (IQR, 3.1–14.0) and 5.3 years (IQR, 3.4–13.1) respectively. …”
  8. 64908

    Table1_Comparison of perventricular and percutaneous ultrasound-guided device closure of perimembranous ventricular septal defects.docx by Liu Liu Huang (17339485)

    Published 2023
    “…</p>Results<p>Patients of the PCP and PVP groups had a median age of 4.9 years (IQR, 3.1–14.0) and 5.3 years (IQR, 3.4–13.1) respectively. …”
  9. 64909

    Table_7_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

    Published 2024
    “…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”
  10. 64910

    Table_8_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

    Published 2024
    “…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”
  11. 64911

    Table_3_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

    Published 2024
    “…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”
  12. 64912

    Table_12_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

    Published 2024
    “…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”
  13. 64913

    Table_3_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

    Published 2024
    “…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”
  14. 64914

    Table_13_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

    Published 2022
    “…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”
  15. 64915

    Data_Sheet_1_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

    Published 2022
    “…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”
  16. 64916

    Table_13_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

    Published 2024
    “…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”
  17. 64917

    Data_Sheet_2_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.DOCX by Beatrice Vione (10734998)

    Published 2024
    “…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”
  18. 64918

    Table_7_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

    Published 2024
    “…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”
  19. 64919

    Table_12_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

    Published 2022
    “…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”
  20. 64920

    Data_Sheet_1_One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.xlsx by Beatrice Vione (10734998)

    Published 2024
    “…</p>Results<p>Results highlight specific alterations of THF with a median concentration ratio DS/control of 2:3, a decrease of a necessary molecule perfectly consistent with a chromosomal dosage effect. …”